# Cost Estimation Analysis of Dementia: A Scope Review

**Authors:** Stella Kalochristianaki, Pinelopi Vlotinou, George Bablekos, Ioanna Giannoula Katsouri, Anna Tsiakiri, Vasiliki Georgousopoulou, Georgia Tsakni

PMC · DOI: 10.7759/cureus.84547 · Cureus · 2025-05-21

## TL;DR

This paper reviews the economic costs of dementia care, focusing on Europe and the US, and highlights the importance of preventive measures to reduce future financial burdens.

## Contribution

The study provides a meta-analysis of dementia care costs and emphasizes the need for preventive strategies and caregiver support.

## Key findings

- Dementia care costs vary significantly between the US and Europe due to healthcare systems and cultural practices.
- Preventive care for high-risk individuals could reduce long-term treatment costs.
- Informal care costs are a major component of dementia care expenses.

## Abstract

Dementia is a progressive neurodegenerative condition, primarily caused by Alzheimer’s disease, predominantly affecting elderly individuals. Under these circumstances, dementia care focuses on assisting patients with daily living, either in nursing facilities or at home. The condition imposes substantial economic burdens on patients, caregivers, and healthcare systems, particularly in Europe and North America, where precise cost assessments are essential.

This review examines the economic impact of dementia care by integrating diverse cost estimation sources to evaluate the cost-effectiveness of preventive care for high-risk individuals and providing meta-analytic estimates of annual medical, non-medical, and informal care costs per patient, and compares these costs with care effectiveness. The analysis focuses on Europe and the United States, with a greater emphasis on Europe, aiming to encourage further research on preventive strategies and caregiver support.

Dementia presents a significant economic challenge globally, driven by rising healthcare costs and an aging population. The disparities between direct and indirect costs in the US and Europe highlight the impact of healthcare systems and cultural practices on dementia care costs. Preventive measures could significantly reduce long-term treatment costs, making them a crucial investment to alleviate future financial burdens.

## Linked entities

- **Diseases:** dementia (MONDO:0001627), Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Diseases:** neurodegenerative condition (MESH:D019636), Dementia (MESH:D003704), Alzheimer's disease (MESH:D000544)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12180423/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12180423/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12180423/full.md

---
Source: https://tomesphere.com/paper/PMC12180423